DE3433678A1 - Dobutamin enthaltendes praeparat zur oralen applikation - Google Patents

Dobutamin enthaltendes praeparat zur oralen applikation

Info

Publication number
DE3433678A1
DE3433678A1 DE19843433678 DE3433678A DE3433678A1 DE 3433678 A1 DE3433678 A1 DE 3433678A1 DE 19843433678 DE19843433678 DE 19843433678 DE 3433678 A DE3433678 A DE 3433678A DE 3433678 A1 DE3433678 A1 DE 3433678A1
Authority
DE
Germany
Prior art keywords
dobutamine
preparations
dbx
plasma
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19843433678
Other languages
German (de)
English (en)
Inventor
Junichiro Fukui Mifune
Noboru Sakai Osaka Nagafuji
Hideo Takarazuka Hyogo Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of DE3433678A1 publication Critical patent/DE3433678A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19843433678 1983-09-16 1984-09-13 Dobutamin enthaltendes praeparat zur oralen applikation Withdrawn DE3433678A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58171594A JPS6061523A (ja) 1983-09-16 1983-09-16 経口用ドブタミン製剤

Publications (1)

Publication Number Publication Date
DE3433678A1 true DE3433678A1 (de) 1985-03-28

Family

ID=15926052

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19843433678 Withdrawn DE3433678A1 (de) 1983-09-16 1984-09-13 Dobutamin enthaltendes praeparat zur oralen applikation

Country Status (5)

Country Link
JP (1) JPS6061523A (ja)
DE (1) DE3433678A1 (ja)
FR (1) FR2551974A1 (ja)
GB (1) GB2146529A (ja)
IT (1) IT1179127B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663351A (en) * 1985-08-23 1987-05-05 Berlex Laboratories, Inc. Dobutamine tri-isobutyric acid ester and the use thereof as a cardiotonic agent
CA2049481A1 (en) * 1990-08-27 1992-02-28 Jill Ann Panetta Method of treating inflammatory bowel disease
US5281623A (en) * 1990-08-27 1994-01-25 Eli Lilly And Company Method for treating inflammation
US5280046A (en) * 1991-02-22 1994-01-18 The University Of Colorado Foundation, Inc. Method of treating type I diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA732136B (en) * 1972-04-12 1974-03-27 Lilly Co Eli Dopamine derivatives
GB1453034A (en) * 1972-12-15 1976-10-20 Boehringer Sohn Ingelheim Pharmaceutical composition for treating spasticity
NZ196349A (en) * 1980-03-07 1984-08-24 Interx Research Corp Enhancement of absorption rate of orally administered polar bioactive agents

Also Published As

Publication number Publication date
GB8423485D0 (en) 1984-10-24
FR2551974A1 (fr) 1985-03-22
JPS6061523A (ja) 1985-04-09
IT8467927A1 (it) 1986-03-14
IT8467927A0 (it) 1984-09-14
IT1179127B (it) 1987-09-16
GB2146529A (en) 1985-04-24

Similar Documents

Publication Publication Date Title
DE69631157T2 (de) Pharmazeutische Zusammensetzung
EP0068191B2 (de) Orale Dipyridamolformen
DE602004010531T2 (de) Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma
EP0257344B1 (de) Arzneimittel enthaltend Dipyridamol oder Mopidamol und O-Acetylsalicylsäure bzw. deren physiologisch verträgliche Salze, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung der Thrombusbildung
WO1997034600A1 (de) Kombinationspräparat, enthaltend 5-methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid und n-(4-trifluormethylphenyl)-2-cyan-3-hydroxycrotonsäureamid
DE69824313T2 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
DE3390116C2 (de) Verbesserte, Koffein enthaltende, analgetische und antiinflammatorische Mittel
DE2520978C3 (de) Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
DE2513940A1 (de) Pharmazeutische zubereitung
EP0169465A2 (de) Kombinationspräparat aus Pyrimido-pyrimidinen und O-Acetylsalicylsäure bzw. deren pharmakologisch verträglichen Salzen und dessen Verwendung
WO1999000122A1 (de) Verfahren zur reduktion des körpergewichtes
DE60219940T2 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
DE3433678A1 (de) Dobutamin enthaltendes praeparat zur oralen applikation
CH677612A5 (ja)
DE3035494A1 (de) Carnitin enthaltendes arzneimittel zur behandlung von hyperlipidaemie und hyperlipoproteinaemie, sowie verwendung von carnitin zur herstellung eines solchen arzneimittels
DE2212840A1 (de) Mittel zur Behandlung kardiovaskulaerer Stoerungen und pharmazeutische Praeparate zu seiner Anwendung
DE19929031A1 (de) Kombination von MTP-Inhibitoren und Lipidsenkern und ihre Verwendung in Arzneimitteln
DE2352618C3 (de) Peroral oder rektal verabreichbares arzneimittel zur behandlung des parkinsonismus
DE19849737A1 (de) Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen
DE60312642T2 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
EP0524512B1 (de) Antihypertensive Kombination
DE3213579C2 (ja)
EP0331871A2 (de) Antipsychotisch wirksames Imidazobenzodiazepin
EP0667151A1 (de) Orale Arzeimittelzubereitung mit Diclofenac-Natrium
DE2132923C3 (de) Arzneimittel zur oralen Therapie der Herzinsuffizienz

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee